These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 2949060

  • 1. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC, Altar CA.
    J Neurochem; 1987 Mar; 48(3):824-31. PubMed ID: 2949060
    [Abstract] [Full Text] [Related]

  • 2. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

  • 3. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 4. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 04; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 5. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 6. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul 10; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 7. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 8. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 10; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 9. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

  • 10. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 29; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism.
    Palacios JM, Wiederhold KH.
    Brain Res; 1985 Feb 18; 327(1-2):390-4. PubMed ID: 3157422
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA, Callahan PM, Appel JB.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):121-5. PubMed ID: 2935415
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr 10; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE, Sutherland JV, Woolverton WL.
    Behav Neural Biol; 1990 May 10; 53(3):378-92. PubMed ID: 1972014
    [Abstract] [Full Text] [Related]

  • 15. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH, Fechtali T, Rostain JC.
    Neuroscience; 1992 Sep 10; 50(2):395-402. PubMed ID: 1359460
    [Abstract] [Full Text] [Related]

  • 16. Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective of their selectivity for D1 or D2 receptors.
    Castellano C, Cestari V, Cabib S, Puglisi-Allegra S.
    Behav Neural Biol; 1991 Nov 10; 56(3):283-91. PubMed ID: 1684703
    [Abstract] [Full Text] [Related]

  • 17. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun 10; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 18. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S, Cabib S.
    Pharmacol Biochem Behav; 1988 Jul 10; 30(3):765-8. PubMed ID: 2974996
    [Abstract] [Full Text] [Related]

  • 19. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM, Dieguez C, Lewis M, Hall R, Scanlon MF.
    Endocrinology; 1986 Oct 10; 119(4):1712-7. PubMed ID: 2428601
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.